75% Objective Response Rate as 12 out of 16 advanced melanoma patients had objective clinical responses, with 11 of the 12 responders continuing to respond at 24 months follow-up Immune activation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback